Contemporary Predictors of Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: A Nationally Representative US Sample.
Benjamin D HorneNipun AtrejaJohn VendittoThomas WilsonJoseph B MuhlesteinJoshua R St ClairKirk U KnowltonNaeem D KhanNarinder BhallaJeffrey L AndersonPublished in: Journal of clinical medicine (2024)
Background : Patient outcomes after percutaneous coronary intervention (PCI) have improved over the last 30 years due to better techniques, therapies, and care processes. This study evaluated contemporary predictors of post-PCI major adverse cardiovascular events (MACE) and summarized risk in a parsimonious risk prediction model. Methods : The Cardiovascular Patient-Level Analytical Platform (CLiPPeR) is an observational dataset of baseline variables and longitudinal outcomes from the American College of Cardiology's CathPCI Registry ® and national claims data. Cox regression was used to evaluate 2-6 years of patient follow-up (mean: 2.56 years), ending in December 2017, after index PCI between 2012 and 2015 (N = 1,450,787), to examine clinical and procedural predictors of MACE (first myocardial infarction, stroke, repeat PCI, coronary artery bypass grafting, and mortality). Cox analyses of post-PCI MACE were landmarked 28 days after index PCI. Results : Overall, 12.4% (n = 179,849) experienced MACE. All variables predicted MACE, with cardiogenic shock, cardiac arrest, four diseased coronary vessels, and chronic kidney disease having hazard ratios (HRs) ≥ 1.50. Other major predictors of MACE were in-hospital stroke, three-vessel disease, anemia, heart failure, and STEMI presentation. The index revascularization and discharge prescription of aspirin, P2Y 12 inhibitor, and lipid-lowering medication had HR ≤ 0.67. The primary Cox model had c-statistic c = 0.761 for MACE versus c = 0.701 for the parsimonious model and c = 0.752 for the parsimonious model plus treatment variables. Conclusions : In a nationally representative US sample of post-PCI patients, predictors of longitudinal MACE risk were identified, and a parsimonious model efficiently encapsulated them. These findings may aid in assessing care processes to further improve care post-PCI outcomes.
Keyphrases
- percutaneous coronary intervention
- coronary artery disease
- cardiovascular events
- coronary artery bypass grafting
- st segment elevation myocardial infarction
- antiplatelet therapy
- st elevation myocardial infarction
- acute myocardial infarction
- acute coronary syndrome
- chronic kidney disease
- atrial fibrillation
- healthcare
- end stage renal disease
- heart failure
- quality improvement
- cardiac arrest
- coronary artery bypass
- case report
- palliative care
- cardiovascular disease
- adverse drug
- aortic stenosis
- low dose
- health insurance
- coronary artery
- high throughput
- type diabetes
- pain management
- left ventricular
- peritoneal dialysis
- cardiac surgery
- chronic pain
- metabolic syndrome
- prognostic factors
- mass spectrometry
- big data
- artificial intelligence
- affordable care act